FIELD: medicine, chemical-pharmaceutical industry. SUBSTANCE: milled fruits of Osage orange are extracted with diethyl ether at the ratio raw and extragent 1:(20-25) for 3-4 days. Evaporated concentrate is purified on the alumina at the ratio 1:3, and the end product is eluted successively with a mixture petroleum ether and chloroform at ratio 2:8 and with chloroform following by evaporation and drying of extract. EFFECT: enhanced specific activity. 1 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PREPARING TOTAL FLAVONOIDS SHOWING RADIOPROTECTIVE EFFECT | 1999 |
|
RU2152794C1 |
METHOD OF PREPARING AGENT SHOWING ANTISCLEROTIC AND CHOLAGOGUE ACTIVITY | 1993 |
|
RU2068269C1 |
METHOD OF PREPARING OF AGENT SHOWING ANTIANAPHYPAXIS ACETION | 1992 |
|
RU2027439C1 |
METHOD OF PREPARING OF AGENT SHOWING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC EFFECT | 1991 |
|
RU2011383C1 |
METHOD OF BULBOCAPNINE PREPARING | 1991 |
|
RU2021813C1 |
PROCESS FOR MANUFACTURE OF MEDICINAL PREPARATION POSSESSING ANTIANAPHYLACTIC PROPERTIES | 1992 |
|
RU2029555C1 |
METHOD OF PREPARING BIOLOGICALLY ACTIVE SUBSTANCE FROM LAMINARIA | 1991 |
|
RU2028153C1 |
METHOD OF PHENOLIC COMPOUNDS SUM PREPARING | 0 |
|
SU1819618A1 |
METHOD OF PRODUCING AGENT POSSESSING ANTISCLEROUS ACTION | 1991 |
|
RU2008910C1 |
METHOD OF OBTAINING FAHLCARINDIOLE | 0 |
|
SU642286A1 |
Authors
Dates
1994-11-15—Published
1992-09-18—Filed